Category: New products
-
Two Therapies Dropped from NIH Covid-19 Trial
A clinical trial testing multiple treatments for people hospitalized with Covid-19 infections is dropping two therapies for not meeting efficacy standards.
-
Crispr Enables Inhaled Flu, Covid-19 Treatment
A biomedical engineering lab designed and tested in lab animals gene-edited therapies for influenza and Covid-19, inhaled by patients with a home device.
-
Small Biz Grant Funds Hibernating Animal Drug Discovery
A company identifying drug targets from genetic processes in hibernating animals is receiving an NIH grant to advance its technology for heart disease.
-
Sensor in Works Detecting Covid-19 Airborne Virus
A company developing graphene bio-computer chips is applying its technology to sensors that quickly detect SARS-CoV-2 viruses in indoor air.
-
Micro Robotic Neuro Therapy Company Underway
A company designing microscale robotic devices to deliver therapies to the central nervous system began work in public on treatments for brain disorders.
-
NSF Funds AI Covid-19 Drug Combo Simulation
National Science Foundation is funding a new system that uses artificial intelligence to find optimal combinations of current drugs to treat Covid-19 disease.
-
Gene-Edited Transplant Organ Company Raises $125M
A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for human transplantation.
-
NIH Assessing Home Covid-19 Diagnostic with App
A home Covid-19 test is being evaluated with a smartphone app, as part of an NIH program to quickly develop Covid-19 diagnostics for widespread use.
-
Trial Shows Home Mosquito Device Cuts Malaria Cases
A clinical trial shows homes installed with devices that attract then kill mosquitos have fewer malaria cases than homes with standard preventions.
-
Tech Companies Partner on Covid-19 Breath Test
A maker of diagnostics that examine exhaled breath and an artificial intelligence chip provider are developing a simple breath test for Covid-19 infections.